Genovate Biotechnology Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 434.25 million compared to TWD 472.72 million a year ago. Net income was TWD 0.372 million compared to TWD 38.73 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.2 TWD | +1.26% | +1.47% | -9.02% |
1st Jan change | Capi. | |
---|---|---|
-9.02% | 82.2M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 4130 Stock
- News Genovate Biotechnology Co., Ltd.
- Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021